We are an emerging commercial-stage company focused on the development and commercialization of innovative gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. These tests are designed to accurately determine the type or status of the disease or to predict a patient’s response to a specific treatment. Based on the test results, healthcare professionals can tailor the treatment to the individual patient.
Contact
SkylineDx BV
Rotterdam Science Tower (18th floor)
Marconistraat 16
3029 AK Rotterdam
The Netherlands
Phone: +31 (0)10 7038410
E-mail: info@skylinedx.com
Web: www.skylinedx.com
The CEO and CFO of SkylineDx talk about the company’s latest product, the MMprofiler™, a prognostic test to determine the level of risk of a multiple myeloma. Also discussed are…
See our Cookie Privacy Policy Here
